In the SELECT trial, semaglutide significantly reduced major cardiovascular events heart attacks, strokes, cardiovascular death, in people with obesity and established heart disease who did not have diabetes
Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer
Thanks to increasing awareness and strong advocacy from national groups like the Obesity Action Coalition to Florida-based organizations like the Florida Obesity Society, weight loss is being treated more like any other medical issue: with science, compassion, and real care options
Dixit TS, Sharma AN, Lucot JB, Elased KM
How GLP-1 medications cause gastroparesis GLP-1 receptors exist throughout the body, including in the stomach and intestines